Centiva Capital, LP Dexcom Inc Transaction History
Centiva Capital, LP
- $4.79 Billion
- Q3 2024
A detailed history of Centiva Capital, LP transactions in Dexcom Inc stock. As of the latest transaction made, Centiva Capital, LP holds 7,900 shares of DXCM stock, worth $589,972. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,900
Previous 3,260
142.33%
Holding current value
$589,972
Previous $369,000
43.36%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding DXCM
# of Institutions
1,015Shares Held
349MCall Options Held
5.66MPut Options Held
5M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.54 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.58 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.34 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.24 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.12 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $28.8B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...